ICU Medical Inc (ICUI) stock
ICUINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3086% above fair value
$176.91−4.96 (-2.73%)
Close on Nov 17, 2026Market cap $4.42BP/E 147.4Yield –
ICU Medical operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
ICU Medical's operating cash flow for the twelve months ending Jun 30, 2026 was $236.37M, up 70.3% year over year. For fiscal 2025 it was $179.85M, down 11.9% from the year before. Over ten years it grew 10.9% a year on average. The highest annual figure on record is $267.54M in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $179.85M | -11.9% |
| FY2024 | Dec 31, 2024 | $204.03M | +22.8% |
| FY2023 | Dec 31, 2023 | $166.20M | – |
| FY2022 | Dec 31, 2022 | -$62.13M | -123.2% |
| FY2021 | Dec 31, 2021 | $267.54M | +20.1% |
| FY2020 | Dec 31, 2020 | $222.75M | +118.6% |
| FY2019 | Dec 31, 2019 | $101.92M | -36.4% |
| FY2018 | Dec 31, 2018 | $160.22M | +3.8% |
| FY2017 | Dec 31, 2017 | $154.42M | +71.7% |
| FY2016 | Dec 31, 2016 | $89.94M | +40.1% |
| FY2015 | Dec 31, 2015 | $64.20M | -3.2% |
| FY2014 | Dec 31, 2014 | $66.34M | +0.9% |
| FY2013 | Dec 31, 2013 | $65.73M | -0.8% |
| FY2012 | Dec 31, 2012 | $66.27M | +2.8% |
| FY2011 | Dec 31, 2011 | $64.49M | +94.9% |
| FY2010 | Dec 31, 2010 | $33.10M | -35.3% |
| FY2009 | Dec 31, 2009 | $51.14M | +68.7% |
| FY2008 | Dec 31, 2008 | $30.32M | -27.0% |
| FY2007 | Dec 31, 2007 | $41.51M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $80.15M | +614.9% |
| Q1 FY2026 | Mar 31, 2026 | $38.91M | -24.2% |
| Q4 FY2025 | Dec 31, 2025 | $60.60M | +50.8% |
| Q3 FY2025 | Sep 30, 2025 | $56.71M | +57.1% |
| Q2 FY2025 | Jun 30, 2025 | $11.21M | -86.3% |
| Q1 FY2025 | Mar 31, 2025 | $51.33M | +12.1% |
| Q4 FY2024 | Dec 31, 2024 | $40.19M | -56.0% |
| Q3 FY2024 | Sep 30, 2024 | $36.10M | +2.7% |
| Q2 FY2024 | Jun 30, 2024 | $81.95M | – |
| Q1 FY2024 | Mar 31, 2024 | $45.79M | +11.0% |
| Q4 FY2023 | Dec 31, 2023 | $91.27M | – |
| Q3 FY2023 | Sep 30, 2023 | $35.16M | +1422.8% |
| Q2 FY2023 | Jun 30, 2023 | -$1.47M | – |
| Q1 FY2023 | Mar 31, 2023 | $41.25M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.71M | -102.1% |
| Q3 FY2022 | Sep 30, 2022 | $2.31M | -97.1% |
| Q2 FY2022 | Jun 30, 2022 | -$61.39M | -212.1% |
| Q1 FY2022 | Mar 31, 2022 | -$1.34M | -102.6% |
| Q4 FY2021 | Dec 31, 2021 | $82.62M | +5.2% |
| Q3 FY2021 | Sep 30, 2021 | $78.84M | +4.4% |
| Q2 FY2021 | Jun 30, 2021 | $54.76M | +87.4% |
| Q1 FY2021 | Mar 31, 2021 | $51.32M | +29.9% |
| Q4 FY2020 | Dec 31, 2020 | $78.53M | +60.7% |
| Q3 FY2020 | Sep 30, 2020 | $75.49M | +48.6% |
| Q2 FY2020 | Jun 30, 2020 | $29.22M | +25.6% |
| Q1 FY2020 | Mar 31, 2020 | $39.52M | – |
| Q4 FY2019 | Dec 31, 2019 | $48.86M | -2.1% |
| Q3 FY2019 | Sep 30, 2019 | $50.80M | -1.0% |
| Q2 FY2019 | Jun 30, 2019 | $23.27M | -70.8% |
| Q1 FY2019 | Mar 31, 2019 | -$21.01M | – |
| Q4 FY2018 | Dec 31, 2018 | $49.93M | -40.9% |
| Q3 FY2018 | Sep 30, 2018 | $51.33M | -48.0% |
| Q2 FY2018 | Jun 30, 2018 | $79.69M | +66.9% |
| Q1 FY2018 | Mar 31, 2018 | -$20.73M | – |
| Q4 FY2017 | Dec 31, 2017 | $84.55M | +298.2% |
| Q3 FY2017 | Sep 30, 2017 | $98.74M | +266.6% |
| Q2 FY2017 | Jun 30, 2017 | $47.75M | – |
| Q1 FY2017 | Mar 31, 2017 | -$76.61M | – |
| Q4 FY2016 | Dec 31, 2016 | $21.23M | – |
| Q3 FY2016 | Sep 30, 2016 | $26.93M | – |
See a number that looks wrong?